Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES VENUS REMEDIES ALKEM LABORATORIES/
VENUS REMEDIES
 
P/E (TTM) x 33.0 14.2 231.7% View Chart
P/BV x 4.3 0.6 731.8% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 ALKEM LABORATORIES   VENUS REMEDIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
VENUS REMEDIES
Mar-22
ALKEM LABORATORIES/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs4,068639 637.1%   
Low Rs2,671261 1,023.8%   
Sales per share (Unadj.) Rs889.4447.8 198.6%  
Earnings per share (Unadj.) Rs140.530.5 461.4%  
Cash flow per share (Unadj.) Rs166.055.5 298.8%  
Dividends per share (Unadj.) Rs34.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs722.4329.4 219.3%  
Shares outstanding (eoy) m119.5713.37 894.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.0 377.3%   
Avg P/E ratio x24.014.8 162.4%  
P/CF ratio (eoy) x20.38.1 250.8%  
Price / Book Value ratio x4.71.4 341.8%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m402,8686,011 6,702.0%   
No. of employees `000NANA-   
Total wages/salary Rs m19,627523 3,750.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,3425,987 1,776.4%  
Other income Rs m1,62783 1,957.5%   
Total revenues Rs m107,9686,070 1,778.8%   
Gross profit Rs m20,380621 3,281.0%  
Depreciation Rs m3,040335 906.4%   
Interest Rs m5245 10,887.7%   
Profit before tax Rs m18,443364 5,065.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,640-43 -3,798.9%   
Profit after tax Rs m16,803407 4,126.1%  
Gross profit margin %19.210.4 184.7%  
Effective tax rate %8.9-11.9 -75.0%   
Net profit margin %15.86.8 232.3%  
BALANCE SHEET DATA
Current assets Rs m84,3542,780 3,033.9%   
Current liabilities Rs m48,053927 5,181.6%   
Net working cap to sales %34.131.0 110.3%  
Current ratio x1.83.0 58.6%  
Inventory Days Days4221 197.1%  
Debtors Days Days65235 27.5%  
Net fixed assets Rs m43,2453,011 1,436.3%   
Share capital Rs m239134 178.9%   
"Free" reserves Rs m86,1344,271 2,016.8%   
Net worth Rs m86,3734,404 1,961.0%   
Long term debt Rs m94387 24.3%   
Total assets Rs m127,5995,791 2,203.3%  
Interest coverage x36.276.7 47.2%   
Debt to equity ratio x00.1 1.2%  
Sales to assets ratio x0.81.0 80.6%   
Return on assets %13.67.1 190.9%  
Return on equity %19.59.2 210.4%  
Return on capital %21.97.7 284.9%  
Exports to sales %18.70-   
Imports to sales %00-   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,9240-   
Fx outflow Rs m3,9110-   
Net fx Rs m16,0130-   
CASH FLOW
From Operations Rs m11,110410 2,709.7%  
From Investments Rs m-14,351-166 8,631.8%  
From Financial Activity Rs m3,796-95 -4,005.2%  
Net Cashflow Rs m580144 403.2%  

Share Holding

Indian Promoters % 57.2 41.8 136.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.2 1.1 1,786.7%  
FIIs % 4.5 1.1 394.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 58.2 73.6%  
Shareholders   79,721 22,015 362.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA    DR. REDDYS LAB    SUN PHARMA    LUPIN    AUROBINDO PHARMA    


More on ALKEM LABORATORIES vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs VENUS REMEDIES Share Price Performance

Period ALKEM LABORATORIES VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 0.31% -0.31% -0.89%
1-Month -3.08% -7.07% -1.85%
1-Year -10.35% -59.00% -6.83%
3-Year CAGR 13.99% 102.96% 20.56%
5-Year CAGR 7.11% 13.27% 10.73%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.